| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8486506 | Vaccine | 2017 | 11 Pages |
Abstract
Overall, this study has demonstrated that Hexon and pVII-modified AdPfCSP vaccine is a promising malaria vaccine which induces strong PfCSP-specific humoral, CD4+ T-cell, and CD8+ T-cell responses and protects against infection with transgenic malaria parasites expressing the PfCSP.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Takayuki Shiratsuchi, Urvashi Rai, Izumi Kaneko, Min Zhang, Shiroh Iwanaga, Masao Yuda, Moriya Tsuji,